OA
ELV icon

Oxbow Advisors’s Elevance Health ELV Stock Holding History

Oxbow Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,506
Closed -$4.86M – 224
2025
Q2 		$4.86M Buy
12,506
+602
+5% +$242K 0.53% 53
2025
Q1 		$5.18M Buy
11,904
+331
+3% +$133K 0.55% 46
2024
Q4 		$4.27M Buy
11,573
+1,147
+11% +$480K 0.5% 51
2024
Q3 		$5.42M Buy
10,426
+54
+0.5% +$28.8K 0.54% 50
2024
Q2 		$5.62M Sell
10,372
-166
-2% -$87.7K 0.66% 39
2024
Q1 		$5.46M Buy
10,538
+63
+0.6% +$31.3K 0.75% 43
2023
Q4 		$4.94M Sell
10,475
-137
-1% -$63.4K 0.75% 36
2023
Q3 		$4.62M Buy
10,612
+9,837
+1,269% +$4.46M 0.73% 35
2023
Q2 		$344K Sell
775
-69
-8% -$31.8K 0.05% 157
2023
Q1 		$388K Sell
844
-109
-11% -$51.9K 0.07% 137
2022
Q4 		$489K Sell
953
-533
-36% -$271K 0.09% 130
2022
Q3 		$675K Hold
1,486
– – 0.11% 132
2022
Q2 		$717K Hold
1,486
– – 0.1% 131
2022
Q1 		$730K Buy
1,486
+43
+3% +$19.7K 0.07% 144
2021
Q4 		$669K Sell
1,443
-220
-13% -$92.6K 0.06% 157
2021
Q3 		$620K Buy
+1,663
New +$632K 0.06% 177
2020
Q2 		– Sell
-3,463
Closed -$786K – 277
2020
Q1 		$786K Sell
3,463
-11,053
-76% -$3.01M 0.13% 133
2019
Q4 		$4.38M Buy
14,516
+237
+2% +$65.2K 0.51% 50
2019
Q3 		$3.43M Buy
+14,279
New +$3.91M 0.46% 56

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Oxbow Advisors's ELV Position: Q3 2025 in Review

Oxbow Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 12,506 shares — an estimated $4.86M sold.

Oxbow Advisors first reported a position in ELV in Q3 2019 and held it in 19 quarters. The position peaked at $5.62M in Q2 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Oxbow Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Oxbow Advisors sold 12,506 Elevance Health shares in Q3 2025, an estimated $4.86M.
  • Oxbow Advisors first reported a position in Elevance Health in Q3 2019 and held it in 19 quarters.
  • Oxbow Advisors's Elevance Health position peaked at $5.62M in Q2 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Oxbow Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.